Skip to Main Content

After months of deliberation, the European Commission has agreed to accelerate the phasing out of animal testing, but stopped short of a complete ban — drawing praise from university and industry groups but outrage from animal rights activists.

The decision was made in response to a citizen’s initiative, which sought to strengthen an existing ban on animal testing in cosmetics that has been in effect for about a decade. The initiative also urged the European Union to avoid further animal testing requirements for chemicals and commit to legislation for creating a plan to phase out all animal testing before the end of the current legislative term.

advertisement

The effort, which drew support from approximately 1.2 million citizens across the European Union, has caused alarm due to an insistence on phasing out animal testing in biomedical research. Some members of the European Parliament and trade groups representing universities and the pharmaceutical industry argued the initiative went too far too quickly because alternatives, in some instances, are lacking.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.